Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Hepatology International|April 13, 2019
A proposed pathologic sub-classification of drug-induced liver injuryTailing Wang, Xinyan Zhao, Chen Shao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 26, 2019
Prolonged interval of total bilirubin decline is an early independent predictive factor of chronic persistent drug-induced liver injuryWenjing Zhu, Lan Wang, Xinyan Zhao, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct SyndromeTingting Lv, Haitian Yu, Xiao Han, et al.
Hepatology International|March 7, 2021
Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis BShuyan Chen, Jialing Zhou, Xiaoning Wu, et al.
Hepatology International|April 2, 2024
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessmentsShuyan Chen, Jialing Zhou, Xiaoning Wu, et al.
Journal of Medical Virology|February 4, 2023
A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti-HBV therapyShuyan Chen, Bingqiong Wang, Jialing Zhou, et al.
Scientific Reports|February 16, 2018
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapyYameng Sun, Jialing Zhou, Xiaoning Wu, et al.
Journal of Medical Virology|October 12, 2023
Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infectionMengyang Zhang, Shuyan Chen, Xiaoning Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2020
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During TherapyYameng Sun, Xiaoning Wu, Jialing Zhou, et al.
Journal of Medical Virology|March 25, 2019
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapyTianhui Liu, Yameng Sun, Jialing Zhou, et al.
Pageof 7